Putnam BioRevolution ETF (SYNB)

Assets	$5.24M
Expense Ratio	0.71%
PE Ratio	36.35
Shares Out	175,000
Dividend (ttm)	$0.21
Dividend Yield	0.72%
Ex-Dividend Date	Dec 5, 2024
Payout Ratio	26.19%
1-Year Return	-0.58%

Volume	10
Open	30.30
Previous Close	30.89
Day's Range	29.70 - 30.30
52-Week Low	28.69
52-Week High	33.23
Beta	1.02
Holdings	35
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

49.91% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	7.48%
Bio-Rad Laboratories, Inc.	BIO	6.32%
Danaher Corporation	DHR	5.83%
Corteva, Inc.	CTVA	5.25%
AbbVie Inc.	ABBV	4.71%
Alphabet Inc.	GOOGL	4.54%
Novonesis A/S	NVZMY	4.39%
AstraZeneca PLC	AZN	3.87%
NVIDIA Corporation	NVDA	3.77%
Eli Lilly and Company	LLY	3.75%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 5, 2024	$0.2139	Dec 9, 2024
Dec 6, 2023	$0.0211	Dec 11, 2023